Personalized treatment for H. pylori infection in veterans
Part of Digestive system clinical trials.
This study compares a treatment plan that is customized to the person's genes with the usual standard care for getting rid of H. pylori, a common stomach infection. The goal is to see if the personalized approach works better for veterans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult veteran (any gender).
- You have an active H. pylori infection (confirmed by a stool test within the last 4 weeks).
- You have never been treated for H. pylori before.
- You do not have severe stomach bleeding, ulcers, or certain cancers that need immediate treatment.
- You are not allergic to penicillin, and are not pregnant or breastfeeding (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.
This study tests a new way to choose antibiotics for H. pylori infection that didn't go away after first treatment. It uses a stool test to look for antibiotic resistance genes, which may help pick a more effective treatment for you.
This study tests a new way to choose antibiotics for H. pylori infection when the usual treatment has failed. By looking at your stool sample, doctors can pick the medicine most likely to work for you.
This trial tests whether a personalized 7-day treatment plan can fully get rid of H. pylori, a common stomach germ. It may help prevent ongoing stomach irritation and ulcers caused by the infection.
This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.
This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.
Hear when a new Helicobacter Pylori trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.